Rabeprazole Sodium DR - Award

SOL #: SPE2D2-26-D-0006Award Notice

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Seymour, IN

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Jan 22, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Logistics Agency (DLA) has awarded a contract for Rabeprazole Sodium DR 20MG Tablets to Golden State Medical Supply, Inc. (GSMS). This award, identified by contract number SPE2D2-26-D-0006, is valued at an estimated $6,915,886.73 over five years and is an Unrestricted acquisition.

Scope of Work

The contract covers the supply of Rabeprazole DR 20MG Tablets in 30, 90, and 500 count bottles. The "Schedule of Supplies/Services" details estimated quantities and unit prices for a Base Year and four Option Years. "Preparation for Delivery" requirements, particularly regarding packaging size as a unit of use, are referenced in the Statement of Work.

Contract Details

  • Contract Number: SPE2D2-26-D-0006
  • Solicitation Number: SPE2D2-25-R-0006
  • Awardee: Golden State Medical Supply, Inc. (GSMS)
  • Award Date: January 15, 2026 (Contracting Officer Signature Date)
  • Total Estimated Value: $6,915,886.73 (for 5 years)
  • Duration: Base Year + 4 Option Years
  • Set-Aside: Unrestricted
  • Product Service Code: 6505 (Drugs And Biologicals)
  • Place of Performance: Manufacturing by Lannett Company, Inc. in Seymour, IN; Packing by Golden State Medical Supply, Inc. in Camarillo, CA.

Award & Evaluation

This award is based on the acceptance of GSMS' offer dated May 15, 2025, and their final proposal revision dated September 23, 2025, which was submitted following Final Proposal Revisions opened on August 20, 2025.

Additional Notes

The contract incorporates numerous FAR and DFARS clauses by reference, covering various terms and conditions, including small business concerns, contract administration, and specific product requirements. Appendix A lists current Pharmaceutical Prime Vendors.

People

Points of Contact

Files

Files

Download

Versions

Version 1Viewing
Award Notice
Posted: Jan 22, 2026
Rabeprazole Sodium DR - Award | GovScope